All companies
Visit website
VITALFLO
OperatingVitalFlo Inc.
Healthcare · Technology · Founded 2017
Helps doctors measure, monitor, and predict their patients' lung health
Valuation cap ⓘ
$7.0M
As of Apr 2023 · from VITALFLO Future Equity SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$261,078
Across 1 round since 2022
Financials
FY2020–FY2021 · from SEC filings · hover any figure for its source$43K
−$159K
2020
$73K
−$742K
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
Income statement
Revenue
$42,877
$72,690
Cost of goods sold
$1,937
$43,118
Gross margin
95%
41%
Net income
-$159,223
-$741,679
Taxes paid
$204
$200
Balance sheet
Cash
$141,748
$712,911
Accounts receivable
$11,619
$16,543
Total assets
$267,729
$877,926
Short-term debt
$75,823
$39,277
Long-term debt
$725,000
$0
Total liabilities
$800,823
$39,277
Other
Headcount
—
8
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$7.0M
Valuation cap
VITALFLO Future Equity SAFE 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $261.1K / $1MInvestors 125Valuation cap $7M
Reg CF annual-report compliance
Delinquent
Filed 0 of 4 annual reports (FY2022–FY2025)
Missing: 2022, 2023, 2024, 2025
125 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001740049
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.